Abivax Sa revenue was $13.53M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was N/A, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ABVX annual revenue was $13.0M, with 152.6% growth year-over-year.
ABVX past revenue growth
How has ABVX's revenue growth performed historically?
On Invalid Date, Abivax Sa (NASDAQ: ABVX) reported Q4 2024 revenue of N/A up N/A year over year. In the same quarter last year, Abivax Sa's revenue was N/A.
What was Abivax Sa's revenue in 2024?
Abivax Sa's annual revenue for the twelve months ending Dec 31, 2024 was $12.97 million, a 152.56% increase year over year.
How much does Abivax Sa make in a day?
Based on Abivax Sa annual revenue for the past three years, ABVX makes an average of $20,984.19 per day.
What was Abivax Sa's annual revenue growth in the past year?
As of Q1 2025, Abivax Sa's revenue has grown 152.56% year over year. This is 268.87 percentage points lower than the US Biotechnology industry revenue growth rate of 421.43%. Abivax Sa's revenue in the past year totaled $13.53 million.
How much does Abivax Sa make in a year?
Abivax Sa's revenue by year for the past three years is:
Abivax Sa's revenue for the twelve months ending Dec 31, 2024 was $12.97 million, a 152.56% increase year over year.
Abivax Sa's annual revenue for Dec 31, 2023 was $5.13 million, a 5.31% increase from 2022.
Abivax Sa's annual revenue for 2022 was $4.88 million, a 64.13% decrease from 2021.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.